Open AccessThrombolytic therapy causes an increase in vascular permeability that is reversed by 1-deamino-8-D-vasopressin.
Author(s) -
Murray A. Rudd,
Michael T. Johnstone,
LeRoy E. Rabbani,
D George,
J. Anthony Ware,
Joseph Loscalzo
Publication year - 1991
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/01.cir.84.6.2568
Subject(s) - medicine , vasopressin , albumin , endocrinology , tissue plasminogen activator , vascular permeability , plasminogen activator , aspirin , bolus (digestion) , plasmin , saline , chemistry , biochemistry , enzyme
To examine the effect of plasminogen activator therapy on vascular permeability, we used a modified rabbit mesenteric model of extravascular tissue accumulation of radiolabeled albumin.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom